Bahl & Gaynor’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-5,355
| Closed | -$246K | – | 396 |
|
|
2016
Q3 | $246K | Sell |
5,355
-55
| -1% | -$2.53K | ﹤0.01% | 372 |
|
|
2016
Q2 | $272K | Buy |
5,410
+5
| +0.1% | +$251 | ﹤0.01% | 371 |
|
|
2016
Q1 | $290K | Buy |
5,405
+360
| +7% | +$19.3K | ﹤0.01% | 360 |
|
|
2015
Q4 | $331K | Sell |
5,045
-32
| -0.6% | -$2.1K | ﹤0.01% | 358 |
|
|
2015
Q3 | $287K | Sell |
5,077
-48
| -0.9% | -$2.71K | ﹤0.01% | 376 |
|
|
2015
Q2 | $303K | Buy |
+5,125
| New | +$303K | ﹤0.01% | 388 |
|
|
2014
Q4 | – | Sell |
-3,920
| Closed | -$211K | – | 429 |
|
|
2014
Q3 | $211K | Buy |
+3,920
| New | +$211K | ﹤0.01% | 405 |
|
|
2014
Q2 | – | Sell |
-8,754
| Closed | -$462K | – | 406 |
|
|
2014
Q1 | $462K | Sell |
8,754
-4,046
| -32% | -$214K | 0.01% | 283 |
|
|
2013
Q4 | $513K | Sell |
12,800
-177,352
| -93% | -$7.11M | 0.01% | 262 |
|
|
2013
Q3 | $7.18M | Sell |
190,152
-7,428
| -4% | -$281K | 0.13% | 96 |
|
|
2013
Q2 | $7.75M | Buy |
+197,580
| New | +$7.75M | 0.15% | 94 |
|